MDA-MB-231-LM2 cells treated with sudemycin D6 (SD6). MDA-MB-231-LM2 cells treated with sudemycin D6 (SD6)
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
The objective is to identify gene expression patterns that occur after spliceosome inhibition in triple-negative breast cancer. Overall design: MDA-MB-231-LM2 cells were treated with vehicle (DMSO) or SD6 for 72 hours, in biological triplicate.
创建时间：
2020-12-17
